다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Sonnet BioTherapeutics Holdings Inc (SONN)
Sonnet BioTherapeutics Holdings Inc (SONN) 뉴스

SONN

Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SONN

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/20	21:30	GlobeNewswire Inc.	Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/06/13	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/06/13	21:00	GlobeNewswire Inc.	Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/28	21:00	GlobeNewswire Inc.	Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/22	20:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/20	22:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/17	05:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/16	05:06	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/15	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/15	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/05/15	05:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/03/11	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/02/14	21:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/02/14	21:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/02/02	06:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/01/30	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/01/05	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2024/01/03	06:19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/12/28	06:56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/12/23	06:31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/12/16	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/12/15	07:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/12/15	07:02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/11/18	01:32	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/11/07	01:35	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/10/28	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/10/28	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc
2023/10/26	22:00	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:SONN	Sonnet BioTherapeutics Holdings Inc

검색 관련기사 보기:NASDAQ:SONN

1 2 3 4 5 6 7 다음 >>

BNP Paribas Issuance

Amsterdam Commodities NV (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관